Self-Reported Influences of Hopelessness, Health Literacy, Lifestyle Action, and Patient Inertia on Blood Pressure Control in a Hypertensive Emergency Department Population

Joyner-Grantham, JaNae; Mount, David L.; McCorkle, Orita D.; Simmons, Debra R.; Ferrario, Carlos M.; Cline, David

doi:10.1097/maj.0b013e3181b473dc

Cited by 36 publications

(46 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…On one hand, the reason behind this might be inability of depressive patients to be compliant to medications and healthy lifestyle (Aggarwal & Mosca, 2010). On the other hand, these patients with uncontrolled hypertension develop psychological distress and a sense of hopelessness surrounding BP control (Joyner-Grantham et al, 2009). The mechanisms behind this depressive behavior leading to hypertension or uncontrolled hypertension might be increased sympathetic stimulation.…”

Section: Discussionmentioning

confidence: 99%

Depression is linked to uncontrolled hypertension: a case–control study from Karachi, Pakistan

Almas¹,

Patel²,

Ghori

et al. 2014

Journal of Mental Health

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Depression is linked to uncontrolled hypertension: a case–control study from Karachi, Pakistan

Almas¹,

Patel²,

Ghori

et al. 2014

Journal of Mental Health

View full text Add to dashboard Cite

show abstract

“…50,51 The patient's health beliefs and attitudes concerning the effectiveness of the treatment, their previous experiences with pharmacological therapies, and lack of motivation also affect the degree of medication adherence. 3,52,53 Medication adherence continues to decline even after a catastrophic event such as a stroke ( Figure 1) 12 ; thus, it is not surprising that treating asymptomatic conditions to prevent the possible occurrence of adverse events years later presents an even greater challenge. Specific factors identified as barriers to medication adherence among inner city patients with low socioeconomic status were high medication costs, lack of transportation, poor understanding of medication instructions, and long wait For personal use.…”

Section: Patient-related Factorsmentioning

confidence: 97%

Medication Adherence: WHO Cares?

Brown

Bussell

2011

Mayo Clinic Proceedings

1,663

1,316

View full text Add to dashboard Cite

The treatment of chronic illnesses commonly includes the long-term use of pharmacotherapy. Although these medications are effective in combating disease, their full benefits are often not realized because approximately 50% of patients do not take their medications as prescribed. Factors contributing to poor medication adherence are myriad and include those that are related to patients (eg, suboptimal health literacy and lack of involvement in the treatment decision-making process), those that are related to physicians (eg, prescription of complex drug regimens, communication barriers, ineffective communication of information about adverse effects, and provision of care by multiple physicians), and those that are related to health care systems (eg, office visit time limitations, limited access to care, and lack of health information technology). Because barriers to medication adherence are complex and varied, solutions to improve adherence must be multifactorial. To assess general aspects of medication adherence using cardiovascular disease as an example, a MEDLINE-based literature search (January 1, 1990, through March 31, 2010) was conducted using the following search terms: cardiovascular disease, health literacy, medication adherence, and pharmacotherapy. Manual sorting of the 405 retrieved articles to exclude those that did not address cardiovascular disease, medication adherence, or health literacy in the abstract yielded 127 articles for review. Additional references were obtained from citations within the retrieved articles. This review surveys the findings of the identified articles and presents various strategies and resources for improving medication adherence.

show abstract

“…5 Anxiety and depression strongly influence the patient's behaviour, leading to social regression, poor medical compliance and even suicide. Such responses decrease quality of life, extend hospital stays and increase medical costs.…”

Section: Introductionmentioning

confidence: 99%

Impact of Depression Mood Disorder on the Adverse Drug Reaction Incidence Rate of Anticancer Drugs in Cancer Patients

et al. 2010

View full text Add to dashboard Cite

The aim of this study was to explore the impact of depression mood disorder on the incidence of adverse drug reactions of anticancer drugs in cancer patients. The Hamilton Depression Scale 17 was used to evaluate the depression mood disorder level in 73 cancer patients before chemotherapy. Pharmacists monitored adverse drug reactions during the chemotherapy period. The relationship between depression mood disorder level and the incidence of adverse drug reactions was analysed. The frequency and extent of total adverse drug reactions were not related to depression mood disorder level. The frequency and extent of subjectively experienced adverse drug reactions such as anorexia, nausea and fatigue were related to depression mood disorder level. In conclusion, psychological support and intervention should be provided to cancer patients in order to improve patient adherence and cancer chemotherapy effectiveness, and to decrease the incidence of adverse drug reactions.

show abstract

Self-Reported Influences of Hopelessness, Health Literacy, Lifestyle Action, and Patient Inertia on Blood Pressure Control in a Hypertensive Emergency Department Population

Cited by 36 publications

References 25 publications

Depression is linked to uncontrolled hypertension: a case–control study from Karachi, Pakistan

Depression is linked to uncontrolled hypertension: a case–control study from Karachi, Pakistan

Medication Adherence: WHO Cares?

Impact of Depression Mood Disorder on the Adverse Drug Reaction Incidence Rate of Anticancer Drugs in Cancer Patients

Contact Info

Product

Resources

About